Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Portage Biotech (PRTG)
:PRTG
Holding PRTG?
Track your performance easily
PRTG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.09 - $25.14
Previous CloseN/A
Volume13.74K
Average Volume (3M)1.31M
Market Cap
$4.44M
Enterprise Value$4.72M
Total Cash (Recent Filing)$59.07M
Total Debt (Recent Filing)$181.00K
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Feb 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jan 04, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-65.69
Shares Outstanding1,121,059
10 Day Avg. Volume54,911
30 Day Avg. Volume1,313,759
Standard Deviation0.32
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Portage Biotech Inc News
PremiumCompany Announcements
Portage Biotech Re-Launches Subsidiary as Cyncado Therapeutics with New CEO
PremiumCompany Announcements
Portage Biotech Enters Negotiations with Immunova for iOx Acquisition
PremiumCompany Announcements
Portage Biotech Inc. Appoints New CEO Amid Leadership Change
PremiumCompany Announcements
Portage Biotech Receives Nasdaq Noncompliance NoticeOwnership Overview
―
Insiders
0.04% Mutual Funds
10.47% Other Institutional Investors
89.49% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRTG FAQ
What was Portage Biotech’s price range in the past 12 months?
Portage Biotech lowest stock price was $2.09 and its highest was $25.14 in the past 12 months.
What is Portage Biotech’s market cap?
Portage Biotech’s market cap is $4.44M.
When is Portage Biotech’s upcoming earnings report date?
Portage Biotech’s upcoming earnings report date is Feb 26, 2025 which is in 36 days.
How were Portage Biotech’s earnings last quarter?
Portage Biotech released its earnings results on Nov 26, 2024. The company reported -$1.26 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.26.
Is Portage Biotech overvalued?
According to Wall Street analysts Portage Biotech’s price is currently Overvalued.
Does Portage Biotech pay dividends?
Portage Biotech pays a Notavailable dividend of $948 which represents an annual dividend yield of N/A. See more information on Portage Biotech dividends here
What is Portage Biotech’s EPS estimate?
Portage Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Portage Biotech have?
Portage Biotech has 1,121,059 shares outstanding.
What happened to Portage Biotech’s price movement after its last earnings report?
Portage Biotech reported an EPS of -$1.26 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.552%.
Which hedge fund is a major shareholder of Portage Biotech?
Currently, no hedge funds are holding shares in PRTG
---
Company Description
Portage Biotech
Portage Biotech, Inc. is engaged in researching & developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs and orphan drugs. It sells and licenses the products to large pharmaceutical companies for further development and commercialization. The company was founded in 1973 and is headquartered in Toronto, Canada.
---
Technical Analysis
---